Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System

Exclusion criteria

• . Subject has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin.
• . Subject is pregnant, attempting to conceive or not willing and able to practice birth control during the study duration (applicable to female subjects only).
• . Subject has skin lesions, scarring, redness, infection or edema at the application sites that could interfere with device placement or the accuracy of interstitial glucose measurements.
• . Subject currently is participating in another clinical trial.
• . Subject has donated blood within 112 days (3.7 months) prior to the beginning of the study activities.
• . Subject has concomitant medical condition which, in the opinion of the investigator, could interfere with the study or present a risk to the safety or welfare of the subject or study staff. Such conditions include but are not limited to:
• . Subject has a known medical condition that, in the opinion of the investigator, may increase the risk of bleeding.
• . Subject has X-ray, MRI or CT appointment scheduled during the period of study participation, and the appointment cannot be rescheduled for a time before study participation starts or after study participation ends.